Intellectual Property India Publishes Patent Application for 'Anti-Kit Antibody Formulations And Methods' Filed by Celldex Therapeutics, Inc.

MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202547015925 A) filed by Celldex Therapeutics, Inc., Hampton, U.S.A., on Feb. 24, for 'anti-kit antibody formulations and methods.'

Inventor(s) include Goldstein, Joel; and Gauden, Magdalena.

The application for the patent was published on March 7, under issue no. 10/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are pharmaceutical compositions comprising antibodies that immunospecifically bind to KIT, a receptor tyrosine kinase, and uses thereof. Also provided are kits and methods for producing such pharmaceutical compositions. KIT ( or c-Kit) is a type III receptor tyrosine kinase encoded by the c-kit...